menu menu_open
Brasil
home Sumário navigate_before Anterior Atual Seguinte navigate_next
home Sumário
Letters To The Editor • Braz J Infect Dis 18 (02) • Mar-Apr 2014 • https://doi.org/10.1016/j.bjid.2013.12.001 linkcopy

Open-access Viral genotypes and human rs12979860 polymorphism of the IFNL3 gene in hepatitis C infected patients in Southern Brazil

SCIMAGO INSTITUTIONS RANKINGS

    Dear Editor,

    Hepatitis C virus (HCV) infection is a global health problem and approximately 80% of the patients develop chronic hepatitis C, which can progress to liver cirrhosis and hepatocellular carcinoma. HCV genotype is a classical predictor of the success of the standard treatment (interferon-α in combination with ribavirin). HCV genotype 1 carriers have usually a lower rate of response than patients infected with HCV genotypes 2 and 3.1 Human single nucleotide polymorphisms near the gene for interferon-λ3 (IFNL3; formerly known as IL28B) were also recently associated with spontaneous HCV clearance and sustained response to interferon-based therapy.2 The present study aimed to determine the frequency of the HCV and IFNL3genotypes in hepatitis C patients from the North region of Rio Grande do Sul state, Southern Brazil.

    Adult individuals with chronic hepatitis C attended in referral services for patient care in Passo Fundo (a medium-sized urban center in the North region of Rio Grande do Sul state) were selected from August 2010 to July 2011. Socio-demographic data were obtained from a structured questionnaire and patient medical records were reviewed to obtain clinical and virological information. IFNL3-molecular analysis was performed as previously described.2 The study was approved by the Research Ethics Committee of the Universidade Luterana do Brasil (ULBRA).

    A total of 191 HCV-infected patients were included in the study. Patients were predominantly female (52.9%) and had a mean age of 51.6±11.4 years. Approximately half of the participants (n=92, 48.2%) received blood transfusions and 75 patients (39.3%) reported that this condition was the possible HCV transmission route. Use of sharp objects (26.7%) and needle sharing (17.8%) were also cited as possible transmission factors. HCV genotype 1 was found in 76 (39.8%), genotype 2 in 46 (24.1%) and genotype 3 in 69 patients (36.1%). HCV genotype 1 was significantly more often in users of illicit drugs, while genotype 2 was more frequently found in women and old people. Sixty patients (31.4%) showed the CC, 97 (50.8%) CT and 34 (17.8%) TT IFNL3genotypes (Table 1).

    Thumbnail
    Table 1
    Distribution of socio-demographic and epidemiological characteristics in patients stratified according to HCV genotypes.

    Some HCV genotypes have a restricted geographical distribution (genotypes 4-6), while others (genotypes 1-3) are more broadly disseminated. HCV genotype 1 is the most prevalent in the world.1 In the present study, genotype 1 was also demonstrated in the highest frequency, followed by genotypes 3 and 2, respectively. Other studies in Brazil have also shown the occurrence of these three genotypes, but genotype 1 with frequencies over 60%, while genotype 2 lower than 10%.3 , 4 This unusual high frequency of HCV genotype 2 confirms the results observed in a previous study.5 In the present report it was further demonstrated the high proportion of old women infected with this genotype. IFNL3 CC genotype, a good human prognostic factor of treatment outcome, was also found in a percentage similar to other Brazilian study.2

    In conclusion, the data obtained in the present study have shown a high frequency of HCV genotype 2 in an urban center in Southern Brazil and suggest the HCV genotypes could have different transmission routes.

    REFERENCES

    • 1 Naggie S. Perspective management of hepatitis C virus infection: the basics. Top Antivir Med. 2012;20:154-61.
    • 2 Lunge VR, Da Rocha DB, Béria JU, Tietzmann DC, Stein AT, Simon D. IL28B polymorphism associated with spontaneous clearance of hepatitis C infection in a Southern Brazilian HIV type 1 population. AIDS Res Hum Retrov. 2012;28:215-9.
    • 3 Campiotto S, Pinho JRR, Carrilho FJ, et al. Geographic distribution of hepatitis C virus genotypes in Brazil. Braz J Med Biol Res. 2005;38:41-9.
    • 4 Foccacia R, Baraldo DCM, Ferraz MLG, et al. Demographic and antropometrical analysis and genotype distribution of chronic patients treated in public and private reference centers in Brazil. Braz J Infect Dis. 2004;8:348-55.
    • 5 Paraboni MLR, Sbeghen MD, Wolff FH, Moreira LB. Risk factors for infection with different hepatitis C virus genotypes in southern Brazil. Scient World J. 2012;2012:946954.

    Publication Dates

    • Publication in this collection
      Mar-Apr 2014

    History

    • Received
      25 July 2013
    • Accepted
      05 Dec 2013
    Creative Common - by-nc-nd 4.0
    This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
    vertical_align_top file_download show_chart
    location_on
    Brazilian Society of Infectious Diseases Rua Augusto Viana, SN, 6º., 40110-060 Salvador - Bahia - Brazil, Telefax: (55 71) 3283-8172, Fax: (55 71) 3247-2756 - Salvador - BA - Brazil
    E-mail: bjid@bjid.org.br
    rss_feed Acompanhe os números deste periódico no seu leitor de RSS
    Acessibilidade / Reportar erro